Something else that may be of significant interest.
Department of World Health stated in September 2017:
"Antimicrobial resistance is a global health emergency that will seriously jeopardize progress in modern medicine," says Dr Tedros Adhanom Ghebreyesus, Director-General of WHO. "There is an urgent need for more investment in research and development for antibiotic-resistant infections including TB, otherwise we will be forced back to a time when people feared common infections and risked their lives from minor surgery."
and
"Pharmaceutical companies and researchers must urgently focus on new antibiotics against certain types of extremely serious infections that can kill patients in a matter of days because we have no line of defence," says Dr Suzanne Hill, Director of the Department of Essential Medicines at WHO.
You can find the entire article here http://www.who.int/news-room/detail...unning-out-of-antibiotics-who-report-confirms
Other articles I've read say that without new antibiotics even standard medical procedures will soon become very high risk due to the resistant bacteria.
Now RECCE® 327 to the rescue
In March 2017 Dr Melrose (RECCE® 327 founder) was quoted by The West Australian new paper saying “We have also looked broadly at its other activity, and we’ve found additional activity against viruses like the flu virus, so that seems to be an added attribute.”
You can find entire article here https://thewest.com.au/news/wa/wa-tests-synthetic-antibiotic-ng-b88402090z
My thoughts;
Imagine if all this drug did was cure or successfully treat the common flu, we would be sitting on a gold mine right. So what if we have a drug that tackles superbugs (bacterial infections) but can also combat viruses as well then I guess were sitting on a mine that holds all the worlds precious metals.
Just my thoughts, don't buy in based on my thoughts. Heck don't buy in at all, this way I can snap up some more whilst prices are measured in cents and not dollars.
Thanks,
Baldy
- Forums
- ASX - By Stock
- RCE
- Accelerated Approval for RECCE® 327
Accelerated Approval for RECCE® 327, page-11
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
46.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $118.1M |
Open | High | Low | Value | Volume |
46.5¢ | 46.5¢ | 46.5¢ | $2.131K | 4.582K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1263 | 46.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
46.5¢ | 11173 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 35701 | 0.510 |
1 | 2928 | 0.505 |
2 | 29692 | 0.500 |
1 | 30000 | 0.495 |
1 | 50000 | 0.490 |
Price($) | Vol. | No. |
---|---|---|
0.520 | 6981 | 1 |
0.525 | 27349 | 2 |
0.530 | 10000 | 1 |
0.545 | 1834 | 1 |
0.550 | 54490 | 2 |
Last trade - 12.38pm 04/12/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |